|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:967-972
© 2002 The American Association for Thoracic Surgery
Evolving Technology (ET) |
From the Thoracic Oncology Section, Surgery Branch, Center for Cancer Research,a and the Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center,b National Institutes of Health, Bethesda, Md.
Presented in oral format at the Annual Meeting of the Society of Surgical Oncology, Washington DC, March 16, 2001
Received for publication June 13, 2001. Revisions requested Aug 31, 2001; revisions received Oct 5, 2001. Accepted for publication Oct 26, 2001. Address for reprints: David S. Schrump, MD, Head, Thoracic Oncology Section, Surgery Branch, National Cancer Institute, Building 10, Room 2B07, 10 Center Dr, Bethesda, MD 20892-1502 (E-mail: David_Schrump{at}nih.gov).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Patients with mediastinal and central pulmonary lesions typically undergo conventional CT scanning of the chest, followed by fiberoptic bronchoscopy (FB).
3 CT generates 2-D cross-sectional images of the thorax to provide information regarding peribronchial anatomy. In the evaluation of major endobronchial disease, CT scans have a sensitivity of 63% to 100% and a specificity of 61% to 99%.
4-6 Suboptimal scanning techniques, inappropriate slice thickness, and artifacts between sections may limit the accuracy of airway anatomy defined by conventional CT scans.
7 FB remains the best modality for evaluation of endoluminal and mucosal lesions; however, endoscopy yields no information about the extent of extraluminal disease or airway patency distal to a high-grade stenosis.
8 In addition, FB poses a potential risk to the patient (morbidity 0.8%) because some degree of sedation is required
9; this risk may be increased in patients with advanced intrathoracic disease.
VB, also referred to as computerized tomographic bronchography, uses noninvasive high-resolution CT techniques exploiting the natural contrast between the air in the tracheobronchial tree and the soft tissue of the airway wall to establish a plane for generating the virtual airway
6; the images are used to generate a 3-D model of airway anatomy. Once the virtual airway is created, the viewer can navigate through the airway in a 3-D manner analogous to standard FB. In addition, VB allows for unconventional images, such as retrograde views of endoluminal and extraluminal anatomy.
8 The airway can be manipulated in space and evaluated from multiple angles.
In the present study we sought to examine the utility of VB relative to conventional diagnostic modalities in thoracic oncology patients. Herein we report that VB is an excellent, reproducible, and noninvasive modality that can be used to image tracheobronchial lesions, thus enabling sequential evaluation of treatment response in patients with malignant disease of the thorax. In addition, VB may be helpful in selecting patients for segmental lung resections or ablation of high-grade bronchial stenoses with laser or photodynamic techniques.
| Methods |
|---|
|
|
|---|
Examination technique
For each FB, visualization of the tracheobronchial tree was achieved under the direction of the attending thoracic surgeons (D.S.S. and D.M.N.), who were blinded to results of VB. FB findings that were entered into the database included the presence or absence of obstructive lesions (defined as bronchial narrowing of >50%), endoluminal masses (defined as a mass protruding into the lumen with <50% occlusion), or mucosal lesions (hemorrhage, erythema, or tissue friability).
For each VB, 200 to 300 contiguous 1.25-mm images of the thorax were obtained in only one or two 17-second breath holds by using a multislice helical CT scanner (G.E. LightSpeed QX/i, Milwaukee, Wis).
10 The technique was 1.25 collimation, HS mode (helical pitch 6, 7.5-mm table motion per rotation, 120 kVp, 100 mAs, 0.8-second tube rotation, nonoverlapping reconstructions with a section interval of 1.25 mm and an effective z-axis resolution of approximately 1.6 mm). The manufacturer's standard reconstruction algorithm was used. The multiple scan average dose to the scanned volume was 1.58 rad at the surface and 0.78 rad in the center per examination. Radiation exposure from VB was calculated to be the same or slightly less than that with a conventional thoracic CT scan (James Vucich, Medical Physicist, NIH).
3-D reconstruction and analysis
VB images were reconstructed to 3-D endoscopic views by using commercial software (G.E. Navigator on a G.E. Advantage Windows workstation). The radiologist (R.M.S.) first placed the viewpoint in the proximal trachea. Retrograde inspection of the subglottis was done. The following were reviewed sequentially: antegrade inspection of the trachea, right main stem bronchus, right upper lobe apical B1, right upper lobe posterior B2, right upper lobe anterior B3, bronchus intermedius, right middle lobe, right middle lobe lateral B4, right middle lobe medial B5, right lower lobe superior B6, right lower lobe medial basal B7, right lower lobe anterior basal B8, right lower lobe lateral basal B9, right lower lobe posterior basal B10, left main stem bronchus, left upper lobe, left upper lobe superior division, left upper lobe apical posterior B1+2, left upper lobe anterior B3, lingular, left upper lobe superior lingular B4, left upper lobe inferior lingular B5, left lower lobe superior B6, left lower lobe anteromedial basal B7-8, left lower lobe lateral basal B9, and left lower lobe posterior basal B10.
Abnormalities in the tracheobronchial tree were recorded. The radiologist interpreted all VB images blind to the actual FB results. The presence or absence of obstructive lesions (defined as bronchial narrowing of >50%), endoluminal masses (defined as a mass protruding into the lumen with <50% occlusion), or mucosal lesions (hemorrhage, erythema, or tissue friability) were entered into the database.
The results of VB were compared with actual FB findings at the same anatomic sites. True-positive (TP) results occurred when VB equaled FB when FB visualized a lesion. True-negative (TN) results occurred when VB equaled FB when FB was within normal limits. False-negative (FN) results occurred when VB failed to detect a lesion documented during FB. False-positive (FP) results occurred when VB demonstrated an abnormality, but FB revealed the area to be normal. Sensitivity (TP/[TP+FN]) and specificity (TN/[TN+FP]) of VB were computed.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Fleiter and colleagues
11 reported a series of patients with thoracic malignant disease who underwent VB with a double-detector CT unit and correlative FB. VB images were successfully created in 19 of 20 patients. In one patient a strong heart pulsation produced a motion artifact that prevented accurate reconstruction. Sites of high-grade stenosis were accurately detected with both techniques. VB allowed for accurate anatomic visualization beyond stenoses. Discrete malignant infiltration and extraluminal compression were not visualized by means of VB in 5 patients. Liewald and coworkers
12 evaluated 30 patients with lung cancer using VB and FB. Three-dimensional images were created in all patients. Thirteen obstructive lesions were seen equally well with VB and FB. VB delineated tracheobronchial anatomy beyond high-grade stenosis in 2 patients. However, mucosal lesions were not visualized by means of VB.
12 Rapp-Bernhardt and associates
13 compared VB with FB in 21 patients with esophageal carcinoma infiltrating the tracheobronchial tree. These authors found no statistically significant difference in the location or grading of stenoses when comparing VB with FB. These same authors also evaluated 18 patients with bronchogenic carcinoma. CT and VB were used to evaluate tracheobronchial stenoses that had been detected by means of FB. CT of the chest was found to have a sensitivity of 92.9% and a specificity of 100%. VB was found to have a sensitivity of 93.8% and a specificity of 99.7%.
14
Our experience confirms that of previous investigators who have evaluated the feasibility and utility of VB in patients with primary or metastatic cancers involving the lungs and mediastinum. We noted that the sensitivity of VB was 100% for obstructive stenotic lesions and that VB was effective for visualizing obstructive lesions in poststenotic sites. VB was also effective at detecting peripheral obstructive lesions beyond the size limits of the endoscope in 5 patients. Our study demonstrated that VB had an overall sensitivity of 82% for detecting any abnormality in the tracheobronchial tree. VB was not effective for detection of subtle mucosal abnormalities, including erythema and tissue friability. It is important to note that VB was able to detect 5 of 6 endoluminal lesions. This represents the first report that VB may be useful for reliably detecting endoluminal disease not advanced enough to cause atelectasis or distal pneumonitis detectable by conventional imaging techniques. Hence this modality may be helpful in guiding bronchoscopic evaluation of patients with intermittent hemoptysis.
There are several advantages of VB. The technique is noninvasive, and no additional radiation exposure occurs relative to standard CT scans of the chest. Commercial software allows for the seamless interactivity of 2-D and 3-D images, thereby enhancing the detection of extraluminal and intraluminal disease. Indeed, for every endoluminal position of the virtual endoscope, it is possible to refer to the corresponding cross-sectional images or to other multiplanar reconstructions to evaluate structures outside the bronchial lumen that may have clinical significance. Although this issue was not specifically addressed in the present study, interpretation of VB by radiologists, thoracic surgeons, and pulmonologists should be highly reproducible and reliable, given the objectivity of the imaging techniques and the software used for data analysis. As such, VB may prove to be a highly effective, objective, and reproducible means of assessing treatment response in patients enrolled in clinical protocols. Furthermore, because VB provides accurate information regarding the length of obstructing lesions and the anatomy distal to an obstruction, this modality may prove to be useful for assessing the feasibility of anatomic segmentectomy, as well as that of endobronchial laser or photodynamic therapy, in thoracic oncology patients.
One limitation of VB pertains to the inability to evaluate the mucosal surface of the tracheobronchial tree. Although form can be detected, mucosal color, irregularity, or friability cannot be assessed. Hence at present VB may not be a reliable modality for the detection of premalignant tracheobronchial lesions. However, with continued refinements in acquisition capabilities and image display techniques, such as high-resolution ultrasonography, magnetic resonance imaging, or positron emission tomography scanning, it may soon be possible to evaluate the mucosal surface by means of VB. If this occurs, VB may prove to be an efficient modality for early detection of airway malignant tumors and for assessing response in patients enrolled in chemoprevention protocols. However, because VB does not enable acquisition of tissue samples for histologic or microbiologic analysis, this modality will never completely replace FB for evaluation of lesions in the respiratory tract.
As technology advances, we must justify clinical indications for new and potentially expensive methods. Our current study indicates that VB is an accurate and noninvasive method for evaluating obstructions, endoluminal masses, and poststenotic areas within the airway. Although FB remains the best modality for examining airway patency and mucosal lesions, VB yields additional information regarding bronchial anatomy that may prove useful in the management of patients with malignant disease of the thorax.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. M. Horton, M. R. Horton, and E. K. Fishman Advanced Visualization of Airways with 64-MDCT: 3D Mapping and Virtual Bronchoscopy Am. J. Roentgenol., December 1, 2007; 189(6): 1387 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Heyer, T. G. Nuesslein, D. Jung, S. A. Peters, S. P. Lemburg, C. H. L. Rieger, and V. Nicolas Tracheobronchial Anomalies and Stenoses: Detection with Low-Dose Multidetector CT with Virtual Tracheobronchoscopy--Comparison with Flexible Tracheobronchoscopy Radiology, February 1, 2007; 242(2): 542 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
Fluoroscopy-assisted thoracoscopic resection of pulmonary nodules after computed tomography-guided bronchoscopic metallic coil marking. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 704 - 710. |
||||
![]() |
J. S. Ferguson and G. McLennan Virtual Bronchoscopy Proceedings of the ATS, December 1, 2005; 2(6): 488 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shitrit, P. Valdsislav, A. Grubstein, D. Bendayan, M. Cohen, and M. R. Kramer Accuracy of Virtual Bronchoscopy for Grading Tracheobronchial Stenosis: Correlation With Pulmonary Function Test and Fiberoptic Bronchoscopy Chest, November 1, 2005; 128(5): 3545 - 3550. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jones and T. Athanasiou Is Virtual Bronchoscopy an Efficient Diagnostic Tool for the Thoracic Surgeon? Ann. Thorac. Surg., January 1, 2005; 79(1): 365 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toyota, H. Uchida, H. Ozasa, A. Motooka, S. Sakura, and Y. Saito Preoperative airway evaluation using multi-slice three-dimensional computed tomography for a patient with severe tracheal stenosis Br. J. Anaesth., December 1, 2004; 93(6): 865 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Dheda, C M Roberts, M R Partridge, and I Mootoosamy Is virtual bronchoscopy useful for physicians practising in a district general hospital? Postgrad. Med. J., July 1, 2004; 80(945): 420 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. De Wever, V. Vandecaveye, S. Lanciotti, and J.A. Verschakelen Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications Eur. Respir. J., May 1, 2004; 23(5): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lacasse, S. Martel, A. Hebert, G. Carrier, and B. Raby Accuracy of virtual bronchoscopy to detect endobronchial lesions Ann. Thorac. Surg., May 1, 2004; 77(5): 1774 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shinagawa, K. Yamazaki, Y. Onodera, K. Miyasaka, E. Kikuchi, H. Dosaka-Akita, and M. Nishimura CT-Guided Transbronchial Biopsy Using an Ultrathin Bronchoscope With Virtual Bronchoscopic Navigation Chest, March 1, 2004; 125(3): 1138 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hoppe, H.-P. Dinkel, B. Walder, G. von Allmen, M. Gugger, and P. Vock Grading Airway Stenosis Down to the Segmental Level Using Virtual Bronchoscopy Chest, February 1, 2004; 125(2): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Finkelstein, D. S. Schrump, D. M. Nguyen, S. M. Hewitt, T. F. Kunst, and R. M. Summers Comparative Evaluation of Super High-Resolution CT Scan and Virtual Bronchoscopy for the Detection of Tracheobronchial Malignancies Chest, November 1, 2003; 124(5): 1834 - 1840. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |